A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea CPAP Management.
The effects of telemedicine on adherence in obstructive sleep apnea patients with long-term continuous positive airway pressure (CPAP) use have never been investigated. To examine effects of a telemedicine intervention on adherence in long-term CPAP users. In a prospective, randomized, multicenter non-inferiority trial conducted in 17 sleep centers across Japan, patients who had used CPAP for more than 3 months and were receiving face-to-face follow-up by physicians every one or two months were randomized by a coordinating center in a blind manner to the following 3 groups: (1) follow-up every 3 months accompanied by a monthly telemedicine intervention (Telemedicine group: TM-group), (2) follow-up every 3 months (3-months group: 3M-group) or (3) monthly follow-up (1-month group: 1M-group). Each group was followed up for 6 months. The change in % days with ≥4 h/night of CPAP use from baseline to the end of the study period was evaluated. A decline of ≥5% from baseline was considered deterioration of adherence. Non-inferiority of TM- and 3M-groups compared to the 1M-group according to the number of patients with deterioration of adherence was evaluated with the Farrington and Manning test (non-inferiority margin 15%). Analyzed were 483 patients (median duration of CPAP use, 29 (interquartile range, 12-71) months), and deterioration of adherence was found in 41/161 (25.5%), 55/166 (33.1%) and 35/156 (22.4%) patients in the TM-, 3M- and 1M-groups, respectively. The non-inferiority of the TM-group compared with the 1M-group was verified (difference in % of patients with adherence deterioration, 3.0%, 95% confidence interval (CI) -4.8 - 10.9%, p<0.01). Conversely, the 3M-group did not show non-inferiority to the 1M-group (% difference 10.7%, 95% CI 2.6-18.8%, p=0.19). In the stratified analysis, adherence in TM- and 1M-group patients with poor adherence at baseline improved (TM: 45.8±18.2 to 57.3±24.4%, p<0.01; 1M: 43.1±18.5 to 53.6±24.3%, p<0.01), whereas that of the 3M-group did not (39.3±20.8 to 39.8±24.8 %, p=0.84). Intensive telemedicine support could help to optimize CPAP adherence even after long-term CPAP use. Clinical trial registered at www.umin.ac.jp/ctr/index.htm. (Trial Number: UMIN000023118).